Seroquel 25 mg filmom obložene tablete
| Name | Seroquel 25 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-619090976 |
| Active Substance | quetiapinum |
| Pharmaceutical Form | filmom obložena tableta |
| Strength | 25 mg |
| Packaging [MA Number for Packaging] | 6 tableta u blisteru, u kutiji [HR-H-619090976-01] 20 tableta u blisteru, u kutiji [HR-H-619090976-02] 30 tableta u blisteru, u kutiji [HR-H-619090976-03] 50 tableta u blisteru, u kutiji [HR-H-619090976-04] 60 tableta u blisteru, u kutiji [HR-H-619090976-05] 100 tableta u blisteru, u kutiji [HR-H-619090976-06] |
| Manufacturer | AstraZeneca UK Limited, Macclesfield, Cheshire, Ujedinjeno Kraljevstvo;
AstraZeneca GmbH, Wedel, Njemačka |
| Marketing Authorisation Holder | AstraZeneca d.o.o., Radnička cesta 80, Zagreb |
| Marketing Authorisation Date | 20.04.2016 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/15-02/65 |
| Registration Number | 381-12-01/70-16-07 |
| Composition | jedna filmom obložena tableta sadrži 25 mg kvetiapina (u obliku kvetiapinfumarata) |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | N05AH04 |
| Medicinal product marketed in the Croatia | Ne |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Educational materials for healthcare professionals |
Podsjetnik o važnosti nadziranja metaboličkih parametara tijekom liječenja kvetiapinom, verzija 2 |
